Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
53.09 USD | +0.61% | +0.80% | +17.40% |
Strengths
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+17.40% | 9.99B | B+ | ||
+14.24% | 80.23B | B- | ||
+12.23% | 52.25B | B+ | ||
+7.12% | 49.51B | B | ||
+24.11% | 47.43B | B+ | ||
+16.97% | 43.06B | B+ | ||
+30.23% | 41.91B | B | ||
+2.40% | 29.93B | B | ||
-2.49% | 29.2B | B- | ||
-7.66% | 28.73B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- UNM Stock
- Ratings Unum Group